vegfr3 inhibitor evt801
Generic: VEGFR3 Inhibitor EVT801
vegfr3 inhibitor evt801: 1 clinical trial tracked.
vegfr3 inhibitor evt801 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about vegfr3 inhibitor evt801, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence0 indications · 1 study sponsors
Related indications
No linked indication is available.
Study sponsors
Clinical Trial Registry Records (1)
A Phase 1, First-in-Human, Open-Label Study to Assess the Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid Tumours
Primary endpoint: MTD and / or a RP2D of EVT801 when administered daily to subjects with advanced or metastatic solid tumours.
Interventionalopen32 enrolledStarted 2021-11Completion 2024-112 sites · FranceKazia Therapeutics Limited